← Evidence map

TrialOsteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA2024

One versus 2 years of alendronate following denosumab: the CARD extension.

Joy N Tsai et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

6 papers cite it

2024
2025
2026
this papertrialcites it

The trial

Full record →Abstract, authors, funding and every citing paper · PMID 39112628